Evaluation of a new portable compression device for lymphedema
Official title: An Open-label, Multi-center, Prospective VA Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
Run by Koya Medical, Inc. · NCT06418282 · Data updated 2026-11-12
This study is testing a new portable compression device to see if it helps people with lymphedema and chronic venous issues feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Koya Medical, Inc. Industry-sponsored |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 13, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06418282 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include males and females aged 18 and older with unilateral or bilateral lower extremity edema due to chronic venous insufficiency.
✕Probably not a fit
Patients with cognitive or physical impairments that prevent them from using the device or those who are non-ambulatory may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study is an open-label, multi-center, prospective evaluation of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) aimed at treating lymphedema and phlebolymphedema. The study will assess both the effectiveness of the device and its health economic implications for patients suffering from chronic venous insufficiency. Participants will be monitored for their response to the device and its impact on their condition over the course of the study.
Why it matters
Potential benefit: If successful, this device could significantly improve the management of lymphedema and enhance the quality of life for patients.
How similar studies have gone: Other studies have explored similar compression therapies, but the specific approach of this portable device is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females ≥ 18 years of age * Capable and willing to sign the informed consent and deemed capable of following the study protocol * Subjects must have a diagnosis of unilateral or bilateral lower extremity edema or lower extremity lymphedema/phlebolymphedema as a consequence of chronic venous insufficiency * Subjects who have medical clearance using diagnostic confirmation through venous duplex to rule out DVT and superficial/deep reflux Exclusion Criteria: * Inability or unwillingness to participate in all aspects of study protocol and/or inability to provide informed consent * Individuals with a history or presence of a systemic disorder or condition that could place the subject at increased risk from sequential compression therapy * Subjects must not have any diagnosed cognitive or physical impairment that would interfere with the use of the device * Non-ambulatory individuals * Female: BMI \> 34 (5'4", 200 lbs.) * Male: BMI \> 34 (5'9", 230 lbs.) * (Max circumference at patella 58 cm; Max circumference at gluteal fold 75 cm) * Diagnosis of lipedema * Diagnosis of active or recurrent cancer (\< 3 months since completion of chemotherapy, radiation therapy or primary surgery for the cancer) * Diagnosis of acute infection (in the last four weeks) * Diagnosis of active/open wound/ulcer * Diagnosis of acute thrombophlebitis (in last 2 months) * Diagnosis of pulmonary embolism or deep vein thrombosis within the previous 6 months * Diagnosis of pulmonary edema * Diagnosis of congestive heart failure (uncontrolled/uncompensated) * Diagnosis of chronic kidney disease with acute renal failure * Diagnosis of epilepsy * Subjects with poorly controlled asthma * Any condition where increased venous and lymphatic return is undesirable * Women who are pregnant, planning a pregnancy or nursing at study entry * Participation in any clinical trial of an investigational substance or device during the past 30 days
Where it's running
-
Glenn Jacobowitz
New York, New York, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Boosted compression for lower limb edema
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Resistance exercise for people with lower-limb lymphedema
This study tests whether short periods of supervised resistance exercise, with and without compression garments, change swelling or symptoms in people with lower-limb lymphedema.
-
Tracking body composition changes after breast cancer treatment
This project will see how muscle mass and fat distribution change over two years in adults treated for stage I–III breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.